Answers are grounded in this paper and cite their sources.
BACKGROUND Complete mesocolic excision (CME) with central vascular ligation has been proposed to improve lymph-node harvest compared with standard colectomy for colon cancer, though prior reviews report inconsistent heterogeneity and safety findings. OBJECTIVE This review aims to comprehensively synthesize lymph-node harvest as the primary outcome across the most current available evidence comparing CME with standard colectomy. METHODS PubMed, Cochrane CENTRAL, and ScienceDirect were searched to August 2026 per PRISMA 2020 guidelines. Risk of bias was assessed using RoB 2 and ROBINS-I; certainty was rated using GRADE. Continuous outcomes were pooled as mean differences and dichotomous outcomes as risk ratios using random-effects models in Review Manager (RevMan), with heterogeneity assessed via I² and Tau². Studies reporting outcomes in incompatible formats were synthesized narratively alongside pooled estimates. RESULTS Eighteen studies were included. For lymph-node yield, eight studies (n=926 CME, 1,145 comparator) pooled as mean differences showed CME significantly increased yield (MD 6.62, 95% CI [4.40, 8.84]; I²=80%), reduced after confounder-based subgrouping (confound-free MD 8.78, I²=61%; confounded MD 4.14, I²=58%; p=.010); narratively, all remaining studies reporting yield as medians, graded exposure, or unpooled means also favoured CME without exception. For the ≥12-node threshold, four studies showed no overall difference (RR 1.07, 95% CI [0.95, 1.21]; I²=81%), becoming significant after excluding one outlying study (RR 1.13, 95% CI [1.02, 1.24]; I²=51%); two additional studies reported this narratively, one non-significant and one showing the largest individual effect (94.7% vs. 79.1%, p<.001). Node positivity showed no pooled difference across thirteen studies (RR 0.99, 95% CI [0.87, 1.13]; I²=47%), while narratively synthesized studies showed mixed, largely non-significant findings. Postoperative complications showed no difference across eight pooled studies (RR 1.00, 95% CI [0.88, 1.13]; I²=0%), corroborated narratively across nine further studies with only one exception showing higher non-severe morbidity. CONCLUSIONS CME consistently increases lymph-node harvest without increasing perioperative complications, though evidence certainty remains low-to-moderate and long-term oncological benefit is unconfirmed.
No takes yet. Share an insight, caveat, or question.
Lopez et al. (2026) studied this question.
Synapse has enriched 8 closely related papers on similar clinical questions. Consider them for comparative context: